How Customers Are Advancing Clinical Trials with Medidata

Video transcript: Well, we're spending time with Medidata right now doing work around a clinical data studio, which I think is a fantastic evolution of that. It's starting to bring a lot of the capabilities together. Medidata is, I think, running in the in the absolute right direction to look at clinical data as one big conglomeration of data, safety, efficacy, regardless of the underlying systems. So moving in that direction, I think, is, is very positive for us. It allows us to, I think, get a better view, present the data to the sponsors more rapidly with better quality, and answer the questions that a lot of sponsors have around, you know, where is my study? Where is my data? How are things really performing? That holistic view of clinical data is, I think, probably one of the great differentiators that Medidata is bringing in. Looking at Clinical Data Studio, the primary value that, that I've communicated is clean data faster. Very, very simple, very, very straightforward, very, very powerful. Having that context, all of the clinical data, all of the endpoint data in one place regardless of underlying system, it moves the needle. It eases the, the data cleansing, process, makes things easier for data management, and presents, I I I think, the unified view of the study in a very, very clean and efficient manner for medical. The ability to get uplift on medical, to turn medical reviews around more quickly to give them that holistic view, is is really, really critical. And, of course, tying in risk based monitoring. One of the big challenges with a with with an atomized eClinical architecture is you have a number of different vendors who have slightly different takes on the same data. We're all looking at the same clinical data. If your RBM system has a slightly different view of what the data definitions may be, then your medical visualization or your data management team, the opportunity for drift or confusion in the data, it's magnified. And that's very, very critical to to the success of the trial, obviously. So having a single context that teams can work in, a single set of information, a single set of reports that people can utilize for their own particular goals, their own within the roles is, I think, very, very powerful and gets us out of, again, that stove piping by technology. You know, is it ECOA? Is it EDC? Is it labs? It doesn't matter. It's endpoint data, and we wanna deal with it as endpoint data.